VPD-737 for Treatment of Chronic Pruritus

• Status: Completed
• Trial end date: 2015-04-15
• Target enrollment: 0
• Participant gender: All

Summary

A study of a several doses of a novel treatment for chronic itch compared to placebo for patients whose condition has not responded to other treatments

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Menlo Therapeutics Inc.; Vyne Therapeutics Inc.
• Treatments: Serlopitant

Criteria

Inclusion Criteria:

• Clinical diagnosis of chronic pruritus and unresponsive to current therapies

Exclusion Criteria:

• Have chronic liver or renal disease